Harri Vainio

1.1k citations
10 papers · 851 indexed · h-index 10
Topics
Pharmacogenetics and Drug Metabolism (3 papers)Cancer therapeutics and mechanisms (2 papers)Genomics, phytochemicals, and oxidative stress (2 papers)
Partner nations
FinlandFranceSingapore

In The Last Decade

Harri Vainio

10 papers receiving 807 citations

Peers

Harri Vainio
Comparison fields: 5 of 78
  • Molecular Biology 614
  • Cancer Research 217
  • Pharmacology 146
  • Health, Toxicology and Mutagenesis 109
  • Genetics 102
Replace Toyohiko Aoki with:
Toyohiko Aoki Japan
Yves Barra France
Ronny Fransson-Steen Sweden
J. Schuppler Germany
K J Cole United Kingdom
John R. Henneman United States
Song Ling Poon Canada
Mian-Ying Wang United States
Sui Ke United States
Thane S. Thurmond United States
Harri Vainio relative to Toyohiko Aoki Japan Toyohiko Aoki's profile →
Citations per field
00.5×1.5×1.8×
Toyohiko Aoki · 1×
Citations per year

Countries citing papers authored by Harri Vainio

Since Specialization
Citations

This map shows the geographic impact of Harri Vainio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harri Vainio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harri Vainio more than expected).

Fields of papers citing papers by Harri Vainio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harri Vainio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harri Vainio. The network helps show where Harri Vainio may publish in the future.

Co-authorship network of co-authors of Harri Vainio

This figure shows the co-authorship network connecting the top 25 collaborators of Harri Vainio. A scholar is included among the top collaborators of Harri Vainio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harri Vainio. Harri Vainio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 37
2 85
3 184
4 31
5 33
6 43
7 152
8 44
9 210
10 32

About Harri Vainio

Harri Vainio is a scholar working on Pharmacology, Pathology and Forensic Medicine and Pharmaceutical Science, having authored 10 papers that have together received 851 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Cancer therapeutics and mechanisms (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). The work is most often cited by research in Pharmacology (146 citations), Cancer Research (217 citations) and Molecular Biology (614 citations). Harri Vainio has collaborated with scholars based in Finland, France and Singapore. Frequent co-authors include Ari Hirvonen, Gareth Morgan, Taik Koo Yun, Hai Rim Shin, Kirsti Husgafvel‐Pursiainen, Eivor Elovaara, Sisko Anttila, Antti Karjalainen, Sisko Anttila and Tamie Nakajima. Their work appears in journals such as International Journal of Cancer, Carcinogenesis and Cancer Causes & Control.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026